GB202200885D0 - Nad-augmentation therapy for parkinson's disease - Google Patents
Nad-augmentation therapy for parkinson's diseaseInfo
- Publication number
- GB202200885D0 GB202200885D0 GBGB2200885.8A GB202200885A GB202200885D0 GB 202200885 D0 GB202200885 D0 GB 202200885D0 GB 202200885 A GB202200885 A GB 202200885A GB 202200885 D0 GB202200885 D0 GB 202200885D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- nad
- parkinson
- disease
- augmentation therapy
- augmentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2109138.4A GB202109138D0 (en) | 2021-06-24 | 2021-06-24 | NAD-augmentation Therapy for parkinson's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202200885D0 true GB202200885D0 (en) | 2022-03-09 |
Family
ID=77179707
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2109138.4A Ceased GB202109138D0 (en) | 2021-06-24 | 2021-06-24 | NAD-augmentation Therapy for parkinson's disease |
GBGB2200885.8A Ceased GB202200885D0 (en) | 2021-06-24 | 2022-01-24 | Nad-augmentation therapy for parkinson's disease |
GBGB2200883.3A Ceased GB202200883D0 (en) | 2021-06-24 | 2022-01-24 | Nad-augmentation therapy for parkinson's disease |
GBGB2200884.1A Ceased GB202200884D0 (en) | 2021-06-24 | 2022-01-24 | NAD-augmentation therapy for Parkinson's disease |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2109138.4A Ceased GB202109138D0 (en) | 2021-06-24 | 2021-06-24 | NAD-augmentation Therapy for parkinson's disease |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2200883.3A Ceased GB202200883D0 (en) | 2021-06-24 | 2022-01-24 | Nad-augmentation therapy for parkinson's disease |
GBGB2200884.1A Ceased GB202200884D0 (en) | 2021-06-24 | 2022-01-24 | NAD-augmentation therapy for Parkinson's disease |
Country Status (1)
Country | Link |
---|---|
GB (4) | GB202109138D0 (en) |
-
2021
- 2021-06-24 GB GBGB2109138.4A patent/GB202109138D0/en not_active Ceased
-
2022
- 2022-01-24 GB GBGB2200885.8A patent/GB202200885D0/en not_active Ceased
- 2022-01-24 GB GBGB2200883.3A patent/GB202200883D0/en not_active Ceased
- 2022-01-24 GB GBGB2200884.1A patent/GB202200884D0/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
GB202109138D0 (en) | 2021-08-11 |
GB202200884D0 (en) | 2022-03-09 |
GB202200883D0 (en) | 2022-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3638315A4 (en) | Aadc polynucleotides for the treatment of parkinson's disease | |
IL274648A (en) | New catecholamine prodrugs for use in the treatment of parkinson's disease | |
PL2197883T3 (en) | Catecholamine derivative useful for the treatment of parkinson's disease | |
EP3562514A4 (en) | Gene therapy for treating wilson's disease | |
SG11202011296VA (en) | Compositions and methods for the treatment of parkinson's disease | |
ZA202205344B (en) | Gene therapy for alzheimer's disease | |
IL263188B (en) | Treatment for parkinson's disease | |
EP4196113A4 (en) | Pharmaceutical compositions and methods for treating parkinson's disease | |
IL278813A (en) | Gene therapy for alzheimer's disease | |
EP3902539A4 (en) | Methods for treating parkinson's disease by administering resiniferatoxin | |
AU2022299351A1 (en) | Nad-augmentation therapy for parkinson's disease | |
EP3917502A4 (en) | Methods of treating a patient having parkinson's disease | |
EP3998071A4 (en) | Composition comprising o-cyclic phytosphingosine-1-phosphate for preventing or treating parkinson's disease | |
GB202016425D0 (en) | Treatment regimens for parkinson's disease | |
SG11202102369VA (en) | Compositions and methods for the treatment of parkinson's disease | |
IL288266A (en) | Gene therapy for alzheimer's disease | |
GB202200884D0 (en) | NAD-augmentation therapy for Parkinson's disease | |
IL309468A (en) | Biomarkers for alzheimer's disease treatment | |
IL282562A (en) | Composition and use for the treatment of parkinson's disease and related disorders | |
KR102467285B9 (en) | Pharmaceutical Composition Comprising Woohuangchengsimhwan for Preventing or Treating Parkinson's Disease | |
EP4035669A4 (en) | Preparation of drug for treating alzheimer's disease | |
GB201915753D0 (en) | Alzheimer's disease | |
GB202212082D0 (en) | Treatment regimens for parkinson's disease | |
EP4072568A4 (en) | Methods for treating parkinson's disease | |
EP3943157A4 (en) | Agent for treating parkinson's disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |